Latest news
Cytosorbents Advances Toward Operating Cash Flow Breakeven - TipRanksTipRanks · Fri, 07 Aug 2026 21:04:30 GMTCytoSorbents posts $9.6M Q2 revenue, narrows cash burn and advances DrugSorb-ATR regulatory path - TradingViewTradingView · Fri, 07 Aug 2026 20:13:12 GMTCOP Q2 Earnings Call Reinforces 2029 Free Cash-Flow Path - TradingViewTradingView · Fri, 07 Aug 2026 19:02:00 GMTAVITA Medical Reports Revenue Growth and Targets Cash Flow Breakeven in 2026 - KalkineKalkine · Fri, 07 Aug 2026 03:35:00 GMTAVITA Medical expects cash flow breakeven in fourth quarter 2026 - Stock TitanStock Titan · Thu, 06 Aug 2026 23:06:21 GMTRCEL: Q2 revenue up 18% year-over-year; 2026 guidance raised, cash flow breakeven expected Q4 - TradingViewTradingView · Thu, 06 Aug 2026 21:59:05 GMTRCEL: Q2 2026 revenue up 18% year-over-year; cash flow breakeven expected by Q4 2026 - TradingViewTradingView · Thu, 06 Aug 2026 20:40:50 GMTRCEL: Q2 revenue up 18% year-over-year, guidance raised, and cash flow breakeven expected in Q4 2026 - TradingViewTradingView · Thu, 06 Aug 2026 20:14:05 GMT